Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study

Overview of attention for article published in BMC Cancer, March 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 16,003 followers.

RT @Liferaftgroup: Study reviews impairment of cognitive functioning during Sunitinib or Sorafenib treatments. http://t.co/gPG5iwAWk9

Study reviews impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients. http://t.co/aNobOvfuo5

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.